Tetragenetics, Inc.
Arlington, MA · CIK 0001409403 · Biotech · Acquired
Tetrahymena-based protein expression platform (SionX) for overexpression of eukaryotic membrane and secreted proteins
- Grants
- $2.6M
- 3 awards
- Sector median: 1
- Raised
- $7.1M
- 8 Form D · Sep 2020
- 72 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 15
- 2 granted · 13 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2009201120132015201720192021
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $490,308 | |
| Private capital raised | Form D · SEC | $2,474,231 | |
| Private capital raised | Form D · SEC | $502,000 | |
| Private capital raised | Form D · SEC | $338,191 | |
| Federal grant | Department of Health and Human Services · Phase II · Expanding the use of Tetrahymena as a protein expression platform | $1,689,529 | |
| Private capital raised | Form D · SEC | $336,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Expanding the use of Tetrahymena as a protein expression platform | $758,950 | |
| Private capital raised | Form D · SEC | $1,097,072 | |
| Federal grant | Department of Health and Human Services · Phase II · Expanding the use of Tetrahymena as a protein expression platform | $109,620 | |
| Private capital raised | Form D · SEC | $809,770 | |
| Private capital raised | Form D · SEC | $1,012,497 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1862 | Avotres Inc. | — | $8.0M |
| 1863 | Bit Global Digital Asset Management Co., Ltd. | — | — |
| 1864 | 3D Bio Holdings, Inc. | — | $7.8M |
| 1865 | Tetragenetics, Inc. | — | $7.1M |
| 1866 | Regenerative Medical Solutions Inc | — | $7.0M |
| 1867 | Angarus Therapeutics, Inc. | — | $6.9M |
| 1868 | Evoke Pharma Inc | — | $6.0M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Ellen BaronDirector
- Marco CacciuttoloDirector · Executive Officer
- Theodore ClarkDirector · Executive Officer
- Marc FranzmanExecutive Officer
- Robert GailusDirector
- William GordonDirector · Executive Officer
- Martin GorovskyDirector
- Daniel GrauDirector
- R KahnDirector · Executive Officer
- R. KahnDirector · Executive Officer
- Peter KienerDirector
- Ben MachielseDirector
- Kevin O'BrienExecutive Officer
- John ReillyExecutive Officer
- Christopher TaronDirector
- Alison Taunton-RigbyDirector
Patents
- ANTI-Kv1.3 ANTIBODIES, AND METHODS OF PRODUCTION AND USE THEREOFgranted
- Expression Of Voltage-gated Ion Channels In Ciliatesapplication
- Fusion Proteins Of Ciliate Granule Lattice Proteins, Granular Protein Particles Thereof, And Uses Thereforgranted
- Polypeptide Expression In Ciliatesapplication
- Expression Of Voltage-gated Ion Channels In Ciliatesapplication
- Expression Of Voltage-gated Ion Channels In Ciliatesapplication
- Expression Of Voltage-gated Ion Channels In Ciliatesapplication
- Fusion Proteins Of Ciliate Granule Lattice Proteins, Granular Protein Particles Thereof, And Uses Thereforapplication
- Production Of Aglycosylated Monoclonal Antibodies In Ciliatesapplication
- Production Of Glycoproteins In Genetically Modified Ciliatesapplication
- Production Of Recombinant Proteins In Ciliates And Uses Thereofapplication
- Polypeptide Expression In Ciliatesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.